Significance of combined cardiopulmonary and echocardiographic stress test to distinguish the hemodynamic and metabolic responses of hypertensive patients with or without heart failure

4 December 2019 (00:00 - 00:00)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Matteo Mazzola

University Hospital of Pisa, Pisa (Italy)

6 More presentations in this session

Presentation thumbnail

Detection of symptom related coronary arteries in patients with coronary artery disease by 4D stress echo with adenosine triphosphate

Doctor D. Safonov (Taganrog, RU)

Abstract Slides

Presentation thumbnail

Exercise echocardiographic determinants of exercise tolerance in aortic stenosis

Doctor P. Fazendas (Almada, PT)

Abstract Slides

Presentation thumbnail

Dobutamine stress echocardiography as a screening tool for coronary artery disease detection in patients with end-stage liver disease awaiting transplantation

Doctor C. Kapelios (Athens, GR)

Abstract Slides

Presentation thumbnail

Regional peak systolic longitudinal strain during dipyridamole stress echocardiography in patients with normokinetic response determined by visual assessment

Professor K. Wierzbowska-Drabik (Lodz, PL)

Abstract Slides

Presentation thumbnail

Assessment of functional mitral regurgitation with leg lift and exercise echocardiography using the average pixel intensity method

Doctor V. Kamoen (Roeselare, BE)

Access the full session

Session thumbnail

Poster session 5 - Stress Echocardiography

The Event

EuroEcho 2019

4 December - 7 December 2019

You may be interested in

Congress Presentation

The do’s and don’ts from the EACVI clinical consensus statement on stress echocardiography

Congress Presentation

Stress echocardiography best defines risk

Congress Presentation

Valvular heart disease

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources